Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-06

FDA Approved: TOLVAPTAN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' tolvaptan as a generic drug through an Original Application (ANDA). The product is indicated for the treatment of clinicall…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tolvaptan (tolvaptan)

Snippet

ORIG AP for TOLVAPTAN (TOLVAPTAN)